Abstract
Subgroup Analysis: Efficacy and Safety of Panobinostat in Combination with SC Bortezomib and Oral Dexamethasone in Multiple Myeloma Patients with Lenalidomide-Refractory Disease
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have